For more information please contact the Press Office:
Tel: +49 6221 387-8443
Tel: +49 6221 387-8726
Heidelberg, 1 April 2020 Understanding brain tumours in children The causes of 40 percent of all cases of certain medulloblastomas – dangerous brain tumours affecting children – are hereditary. These are the findings of a recent genetic analysis carried out by scientists from the Korbel group and numerous colleagues around the world.
Heidelberg, 11 March 2020 €2.45 m to investigate leukaemia causes and therapies The Heidelberg-based LeukoSyStem consortium investigates leukaemia stem cells in acute myeloid leukaemia. The German Federal Ministry of Education and Research financially supports this collaboration between Heidelberg University Hospital, HI-STEM gGmbH (German Cancer Research Center), and EMBL.
Heidelberg, 6 February 2020 Scientists explore how females shut off their second X chromosome In their landmark research published in Nature on 5 February, the scientists reveal how SPEN targets and silences active genes on the X chromosome, providing important new insights into the molecular basis of X-inactivation.
Heidelberg, 20 January 2020 Melting reveals drug targets in a living organism An international team led by researchers at EMBL Heidelberg and Cellzome, a GSK company, has developed a technology to systematically identify drug targets in living animals. In their results, published in Nature Biotechnology on 20 January, the scientists mapped protein–drug interactions in rat organs and blood. Their research opens pathways in drug discovery, fundamental biology, and personalised medicine.
Heidelberg, 23 December 2019 EMBL co-develops new method that could facilitate cancer diagnosis Researchers led by EMBL Heidelberg and the Center for Bioinformatics at Saarland University have developed a cheaper and faster method to check for genetic differences in individual cells, which outperforms existing techniques with respect to the information received. This new method could become a new standard in single cell research, and potentially for clinical diagnosis in disease genetics, including cancer. The results have been published in Nature Biotechnology.
Heidelberg, 23 December 2019 Innovative method delivers new insights into the stem cell microenvironment Researchers from EMBL and the German Cancer Research Center (DKFZ) in Heidelberg, Germany, have developed new methods to reveal the three-dimensional organisation of bone marrow at a single cell level. Since bone marrow harbours blood stem cells responsible for life-long blood generation, these results and the new method provides a novel scientific basis to study blood cancer. The results have been published in Nature Cell Biology.
Hinxton, 13 December 2019 Machine learning finds functional human phosphosites Researchers at the EMBL’s European Bioinformatics Institute (EMBL-EBI) have created the largest reference phosphoproteome to date of almost 120 000 human phosphosites. To identify those most likely to be critical, they used a machine learning approach capable of ranking them according to functional importance.
Policy regarding use
Press and Picture Releases
EMBL press and picture releases including photographs, graphics, movies and videos are copyrighted by EMBL. They may be freely reprinted and distributed for non-commercial use via print, broadcast and electronic media, provided that proper attribution to authors, photographers and designers is made.